» Articles » PMID: 25805235

The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better As a Prognostic Factor in Gastric Cancer?

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2015 Mar 26
PMID 25805235
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As indicators of the systemic inflammatory response, the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been proposed to predict the clinical outcome in some cancers. The purpose of this study was to investigate the impact of NLR and PLR on the prognosis of gastric cancer.

Methods: From 2000 to 2009, 1986 consecutive patients who underwent curative surgery for gastric cancer were enrolled. The optimal cutoff value of PLR and NLR was determined according to receiver operating characteristic analysis. We categorized the patients into the high or low PLR and NLR group based on the cutoff value, and the clinical features of these two groups were comparatively analyzed.

Results: The high NLR and PLR groups were significantly associated with poor prognosis. The NLR was an independent prognostic factor for overall survival [hazard ratio (HR) = 1.403; p = 0.023]; however, the PLR was not (p = 0.788).

Conclusions: Although both the PLR and NLR can reflect the prognosis, the NLR is more predictive of overall survival than the PLR.

Citing Articles

Prognostic and clinicopathological value of systemic immune-inflammation index in patients with osteosarcoma: a meta-analysis.

Wang X, Wu Z, Zhang Z, Jiang Z Front Immunol. 2024; 15:1416068.

PMID: 39211035 PMC: 11357927. DOI: 10.3389/fimmu.2024.1416068.


Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer.

Ba Z, Zhu X, Li Z, Li Y World J Gastroenterol. 2024; 30(24):3059-3075.

PMID: 38983960 PMC: 11230058. DOI: 10.3748/wjg.v30.i24.3059.


Trajectories of neutrophil-to-lymphocyte ratios during neoadjuvant chemotherapy correlate with short- and long-term outcomes in gastric cancer: a group-based trajectory analysis.

Zheng H, Wang F, Zhang L, Li P, Zheng C, Chen Q BMC Cancer. 2024; 24(1):226.

PMID: 38365617 PMC: 10873962. DOI: 10.1186/s12885-024-11950-2.


Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals.

Jarmuzek P, Defort P, Kot M, Wawrzyniak-Gramacka E, Morawin B, Zembron-Lacny A Int J Mol Sci. 2023; 24(22).

PMID: 38003396 PMC: 10671437. DOI: 10.3390/ijms242216206.


Applying artificial intelligence using routine clinical data for preoperative diagnosis and prognosis evaluation of gastric cancer.

Kuwayama N, Hoshino I, Mori Y, Yokota H, Iwatate Y, Uno T Oncol Lett. 2023; 26(5):499.

PMID: 37854867 PMC: 10579989. DOI: 10.3892/ol.2023.14087.